Literature DB >> 20197544

Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.

Martha Stapels1, Chelsea Piper, Tao Yang, Minghua Li, Cheri Stowell, Zhi-gang Xiong, Julie Saugstad, Roger P Simon, Scott Geromanos, James Langridge, Jing-quan Lan, An Zhou.   

Abstract

Exposing the brain to sublethal ischemia affects the response to a subsequent, otherwise injurious ischemia, resulting in transcriptional suppression and neuroprotection, a response called ischemic tolerance. Here, we show that the proteomic signature of the ischemic-tolerant brain is characterized by increased abundance of transcriptional repressors, particularly polycomb group (PcG) proteins. Knocking down PcG proteins precluded the induction of ischemic tolerance, whereas in an in vitro model, overexpressing the PcG proteins SCMH1 or BMI1 induced tolerance to ischemia without preconditioning. We found that PcG proteins are associated with the promoter regions of genes encoding two potassium channel proteins that show decreased abundance in ischemic-tolerant brains. Furthermore, PcG proteins decreased potassium currents in cultured neuronal cells, and knocking down potassium channels elicited tolerance without preconditioning. These findings reveal a previously unknown mechanism of neuroprotection that involves gene repressors of the PcG family.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197544      PMCID: PMC3878609          DOI: 10.1126/scisignal.2000502

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  39 in total

1.  A gene complex controlling segmentation in Drosophila.

Authors:  E B Lewis
Journal:  Nature       Date:  1978-12-07       Impact factor: 49.962

2.  A novel member of murine Polycomb-group proteins, Sex comb on midleg homolog protein, is highly conserved, and interacts with RAE28/mph1 in vitro.

Authors:  D Tomotsune; Y Takihara; J Berger; D Duhl; S Joo; M Kyba; M Shirai; H Ohta; Y Matsuda; B M Honda; J Simon; K Shimada; H W Brock; F Randazzo
Journal:  Differentiation       Date:  1999-12       Impact factor: 3.880

3.  Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins.

Authors:  Ying-Qing Yu; Martin Gilar; Peter J Lee; Edouard S P Bouvier; John C Gebler
Journal:  Anal Chem       Date:  2003-11-01       Impact factor: 6.986

Review 4.  Polycomb group proteins: navigators of lineage pathways led astray in cancer.

Authors:  Adrian P Bracken; Kristian Helin
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

5.  Potassium channel blockers attenuate hypoxia- and ischemia-induced neuronal death in vitro and in vivo.

Authors:  Ling Wei; Shan Ping Yu; Frank Gottron; B Joy Snider; Gregory J Zipfel; Dennis W Choi
Journal:  Stroke       Date:  2003-04-03       Impact factor: 7.914

6.  Mode of action of a homoeotic gene in Drosophila melanogaster. Localization and dosage effects of Polycomb.

Authors:  J Puro; T Nygrén
Journal:  Hereditas       Date:  1975       Impact factor: 3.271

7.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

8.  Functional differences in Kv1.5 currents expressed in mammalian cell lines are due to the presence of endogenous Kv beta 2.1 subunits.

Authors:  V N Uebele; S K England; A Chaudhary; M M Tamkun; D J Snyders
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

9.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

Authors:  J B Bederson; L H Pitts; S M Germano; M C Nishimura; R L Davis; H M Bartkowski
Journal:  Stroke       Date:  1986 Nov-Dec       Impact factor: 7.914

10.  Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states.

Authors:  Mary P Stenzel-Poore; Susan L Stevens; Zhigang Xiong; Nikola S Lessov; Christina A Harrington; Motomi Mori; Robert Meller; Holly L Rosenzweig; Eric Tobar; Tatyana E Shaw; Xiangping Chu; Roger P Simon
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

View more
  53 in total

1.  Eradicating the mediators of neuronal death with a fine-tooth comb.

Authors:  R Suzanne Zukin
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

2.  Enhanced hypoxic preconditioning by isoflurane: signaling gene expression and requirement of intracellular Ca2+ and inositol triphosphate receptors.

Authors:  Philip E Bickler; Christian S Fahlman
Journal:  Brain Res       Date:  2010-04-29       Impact factor: 3.252

3.  Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death.

Authors:  Ross C McKiernan; Eva M Jimenez-Mateos; Takanori Sano; Isabella Bray; Raymond L Stallings; Roger P Simon; David C Henshall
Journal:  Exp Neurol       Date:  2012-07-05       Impact factor: 5.330

4.  Regulation of gene expression in ischemic preconditioning in the brain.

Authors:  Tuo Yang; Qianqian Li; Feng Zhang
Journal:  Cond Med       Date:  2017-12-15

Review 5.  The emerging field of epigenetics in neurodegeneration and neuroprotection.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 6.  Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.

Authors:  David Brand; Rajiv R Ratan
Journal:  Transl Stroke Res       Date:  2013-01-08       Impact factor: 6.829

Review 7.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

8.  Nascent proteomes in peripheral blood mononuclear cells as a novel source for biomarker discovery in human stroke.

Authors:  Fang Bian; Roger P Simon; Yun Li; Larry David; Jolita Wainwright; Casey L Hall; Michael Frankel; An Zhou
Journal:  Stroke       Date:  2014-02-20       Impact factor: 7.914

Review 9.  The epigenetics of stroke recovery and rehabilitation: from polycomb to histone deacetylases.

Authors:  Jessica Elder; Mar Cortes; Avrielle Rykman; Justin Hill; Saravanan Karuppagounder; Dylan Edwards; Rajiv R Ratan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 10.  Reprogramming the response to stroke by preconditioning.

Authors:  Susan L Stevens; Keri B Vartanian; Mary P Stenzel-Poore
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.